Related Experiment Video

Updated: Aug 23, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies

Bradley F Boeve1, Michael H Silber, Tanis J Ferman

  • 1Sleep Disorders Center, Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. bboeve@mayo.edu

Journal of Geriatric Psychiatry and Neurology
|August 18, 2004
PubMed

Insights

Rapid eye movement sleep behavior disorder (RBD) involves acting out dreams during REM sleep. Management includes safety counseling and medications like clonazepam or melatonin, with growing evidence of its link to neurodegenerative diseases.

Area of Science:

  • Neurology
  • Sleep Medicine
  • Neuroscience

Background:

  • Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by motor activity during REM sleep, often mirroring dream content.
  • Patients with RBD may physically act out vivid or frightening dreams.
  • Current management focuses on environmental safety and pharmacotherapy, with clonazepam and melatonin being common treatments.

Purpose of the Study:

  • To provide a comprehensive review of Rapid eye movement sleep behavior disorder (RBD).
  • To discuss the clinical, polysomnographic, and diagnostic features of RBD.
  • To explore the association between RBD and neurodegenerative diseases, particularly Parkinson's disease and dementia with Lewy bodies.

Main Methods:

  • Review of clinical and polysomnographic features of RBD.
  • Analysis of differential diagnosis and diagnostic criteria for RBD.
  • Examination of management strategies and pathophysiologic mechanisms of RBD.
  • Literature review and institutional experience of RBD in neurodegenerative disease.

Main Results:

  • RBD is characterized by dream-enacting behaviors during REM sleep.
  • Effective management strategies include safety counseling and medications such as clonazepam and melatonin.
  • RBD is increasingly recognized as potentially significant in isolation and in association with neurodegenerative conditions.

Conclusions:

  • RBD is a significant parasomnia with implications for patient safety.
  • Effective management strategies are available for RBD.
  • Emerging data highlight the potential diagnostic and pathophysiologic importance of RBD in the context of neurodegenerative diseases like Parkinson's disease and dementia with Lewy bodies.

More Related Videos

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

Related Concept Videos

REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.